Mathews Journal of Case Reports

  • likes
  • Followers
  • Subscribers
  • Latest Tweets
    Facebook Likes

    Current Issue Volume 4, Issue 4 - 2019

    Paraplegia Caused by Systemic Myopericytomas in an AIDS Patient: A Rare Case

    Chai Zhaohui1#, Tao Ran2#, Tang Lingling2, Zhu Biao2, Cheng Jinlin3, Zheng Jiesheng1*

    1Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, China

    2Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, China

    3State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, China

    *Corresponding Author: Zheng Jiesheng, Department of Neurosurgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Qingchun Road, Hangzhou, Zhejiang, 310003, China.

    # Chai ZH and Tao R contributed equally to this work.

    Citation: Chai ZH. (2019). Paraplegia Caused by Systemic Myopericytomas in an AIDS Patient: A Rare Case. Mathews J Case Rep 4(5): 61.



    Background: Myopericytoma is a rare type of perivascular neoplasm that arises from the skin and peripheral soft tissues. Cases associated with AIDS are even rarer.

    Case Description: We present a case of a 31-year-old patient who diagnosed AIDS for 3 years and gradually occurred neuropathy for 1 month. The magnetic resonance imaging (MRI) scan showed multifocal lesion along the spinal canal. The patient was finally diagnosed as systemic myopericytomas. Histopathology revealed myopericytomas. Immunochemistry revealed smooth muscle actin (SMA), Epstein-Barr virus encoded small RNA (EBER) and caldesmon were all positive. Meanwhile, the staining of desmin, S-100 protein, CD34, pancytokeratin (CK-pan) were negative. High-throughput genetic test revealed EBV infection in the tumor tissue. The patient has no evidence of recurrence 9 months after surgery.

    Conclusion: The myopericytomas in spinal canal was relatively rare. The case we report is the most multifocal tumor to date. Surgery maybe the only treatment and it was reported that EBV may be related to the occurrence of myopericytomas.


    Keywords: Spinal canal; Myopericytoma; AIDS; EBV.


    Abbreviations: MRI: Magnetic resonance imaging; SMA: smooth muscle actin, EBER: Epstein-Barr virus encoded small RNA; CK-pan: pancytokeratin; EBV: Epstein-Barr virus; HMB-45: human melanoma black-45; EMA: epithelial membrane antigen; HHV8: human herpes virus 8.



    Myopericytoma is a slow-growing benign perivascular neoplasms located in subcutaneous tissues and the etiology is unknown [1]. It was first reported by Granter et al. in 1998. And since then WHO has classified it as a soft tissue tumor [2]. It has been reported that typical myopericytomas are found in the skin and superficial soft tissues, it often located in the distal or proximal limb, such as the subcutaneous tissues at the tip of the finger, and occasionally in the trunk, head, neck, etc. A few cases are in the oral cavity, nasal cavity and larynx. The myopericytomas in the brain, heart, lung, gastrointestinal tract and other internal organs are rarely reported [3,4]. Tumor cells typically bulging into the lumen of a vessel. It often presents in a pattern as isolated and painless. The growth of myopericytoma is usually well-circumscribed, but there have been reports described that it may extend along blood vessels outside of the lesion [5]. Myopericytoma involving the nervous system is very rare. Intracranial myopericytoma has been firstly reported by Rousseau et al. [6]. We report a case of a multifocal myopericytoma involving the spinal canal in an AIDS patient.



    A 31-year-old male was admitted to the first affiliated hospital of medical college of Zhejiang University in July, 2018 due to "Diagnosed AIDS for more than 3 years and gradually developed weakness in both lower limbs for 3 months". The patient presented with the loss of superficial sensation and proprioceptive sensation below the processus xiphoideus. The sensation between the T3 and processus xiphoideus was abnormal. Upon physical examination, Paraplegia and hypoesthesia below the level of nipple, muscle strength of both upper limbs graded V, muscle strength of both lower limbs graded 0. Reflex of Babinski's sign was positive. He was diagnosed with AIDS at the local hospital 3 years ago and began to receive HAART (Tenofovir+ Lamivudine+ Efavirenz). After 2 years of antiretroviral therapy, the patient spontaneously stopped taking the drug. More than 1 month ago, the patient developed weakness in both lower limbs and was unable to walk. Multiple abnormal enhancement lesions were found in the T2, T4, T6, and the L5 and S1, which were considered as neurogenic tumors. HAART (Tenofovir+ Lamivudine+ Efavirenz) was restarted. Probably due to the poor compliance, he remained immunodeficient with a CD4+ count of 166/μL, CD4+/CD8+: 0.15. Whole body tomography showed multifocal increase of FDG metabolism (Figure 1). In addition, the Magnetic Resonance Imaging (MRI) revealed multiple nodular abnormal signal shadows were observed in the spinal canal at T2/3, T4, T6 and T10 levels, with low signal on T1-weighted axial images and slightly high signal on T2-weighted axial images, and obvious enhancement was observed in the lesions on enhanced scan, the larger one was located at T2/3 level, with a size of about 2.6 x 1.0cm, and the compression and spinal stenosis in the corresponding levels of spinal cord were observed, especially at T2/3 level (Figure 2A,B,C). There was a columnar space occupying lesion in the extramedullary dura of the spinal canal at the level of L5-S1, with a clear boundary and a size of about 6.3 x 2.2 x 1.8cm. T1-weighted axial images showed equal signal, and T2-weighted axial images showed slightly higher signal, with obvious enhancement but there were some unenhanced areas in the center, and the spinal cord compressed without enhancement. (Figure 2 D,E,F). The examination of Epstein-Barr virus (EBV) DNA showed 6.29×104 copies/ml.


    Figure 1: Whole body tomography showed 1. There were multifocal soft tissue density mass shadows and nodule shadows in both adrenal areas, with uneven increase of FDG metabolism (A), and multiple enlarged lymph nodes in bilateral inguinal, bilateral pelvic wall and anterior sacral, with abnormal increase of FDG metabolism (B). There were multiple high-low density flaky shadows on both sides of the anterior edge of C7, right upper arm, subcutaneous of bilateral buttocks, and inner edge of the left quadratus lumbosum muscle, with abnormal increase of FDG metabolism. Multifocal abnormal increase of FDG metabolism in T2, L5, S1 and S2 intramedullary and extramedullary spinal canal (C).



    Figure 2: Thoracic MRI scan: Multifocal occupations and stenosis in intraspinal canals of T2/3, T4, T6, T10 and in the left margin of the erector spinae muscles of T7/, T11/12 (A, B, C). Lumbar MRI scan: intraspinal occupying lesion in the level of L5-S1. (D, E, F).


    After admission to the hospital, he received treatment for AIDS and corresponding infection then received a biopsy of an inguinal lymph node, the pathological result showed myopericytoma. The patient was offered surgery for diagnosis and due to the inconvenience caused by paraplegia. A complete resection of the entities in spinal canal was performed. Histologically, the lesion was composed of spindle shaped cells that forms bundles orientated in a variety of directions, with a slightly ‘whorling’ pattern and a concentric arrangement of cells around plenty of variably-sized blood vessels. Nuclear atypia and mitotic figures were rarely found. It showed immunoreactivity for SMA, EBER, caldesmon and had a ki-67 index of about 10%. The staining of desmin, S-100 protein, CD34, CK-pan, CD117, DOG-1, human melanoma black (HMB)-45, CD31, epithelial membrane antigen (EMA) and human herpes virus (HHV8) were all negative (Figure 3). Infectious pathogens in the tumor tissue were detected by high-throughput genetic testing assay. The result showed 990 sequences, suggesting that this is human herpes virus type 4 (Epstein-Barr virus) of the lymphocryptovirus, while no bacterial, fungal, parasitic, chlamydia/mycoplasma, mycobacterium tuberculosis gene sequences were detected.



    The patient's condition was not significantly relieved after the operation and discharged one month later. There is no evidence of recurrence 9 months after the surgery, the patient demonstrated that the sensory disturbance was relieved, the sensation between the xiphoid process to the umbilicus returned to normal, but the sensation below the umbilicus was still absent.



    The morphological and immunohistochemical characteristics of myopericytoma were firstly described in 1998. Patients with myopericytoma are more common in middle-aged men [1,5]. In terms of gender difference, the ratio of male to female is 1.25, but no further research described the mechanisms with the differences in gender [3]. Myopericytoma is a benign mesenchymal tumor, rather rare located around blood vessels in soft tissues. The diameter of myopericytoma is generally less than 2cm [5]. It is thought to be consisted of myoid cells perivascular [7] and with no invasion to the surrounding tissues. It was usually unencapsulated and consisted of oval-to spindle-shaped neoplastic cells [6,7]. The cytoplasm of primitive spindle cells was scant and grew around the branched vessels, while the peripheral myoid cells were abundant in eosinophilic cytoplasm, showing a fascicular or whorled appearance in the myxoid matrix [8]. The clinical manifestations of myopericytoma are generally atypical with only 4% of patients relapsed after resection [9,10]. The clinical and imaging features are nonspecific, and are likely to be diagnosed as a more aggressive type of tumor, because the symptoms are primarily characterized by compression of adjacent structures [6].


    Since myopericytoma is a kind of muscle-like cell, it is necessary to distinguish it from glomus tumor, myofibroma, hemangiopericytoma and angioleiomyoma morphologically. The morphologically distinguish of myopericytoma is not easy. The immunohistochemical staining becomes very important for the diagnosis of myopericytoma. It is showed that smooth muscle actin and calmodulin are positive, while CD34, XIII factor, desmin are usually negative [7,8]. Glomus tumor cells surround small blood vessels and are composed of small, single, cuboidal or round epithelial cells. Immunohistochemically, it is positive for SMA while it is negative for desmin and CD34 is positive in varying degrees, however, glomus tumor does not have the ‘onion-skin’-like proliferation of plump spindle-to-round cells as myopericytoma. Infantile myofibroma/myofibromatosis is a common fibroblastic/myofibroblastic proliferation in infancy and childhood, presenting spindle nodular hyperplasia, but these spirals present regional distribution, immunohistochemical showed positive for actin and vimentin, and negative for desmin and CD34 [4]. The tumor cells of hemangiopericytoma were spindle-to-oval, demonstrate intratumoral staghorn-type vasculature, without obvious concentric proliferation. They expressed CD34 and CD99 but did not express SMA and desmin. Angioleiomyoma has elongated and spindle shaped tumor cells surrounding the thick-walled vessels with irregular expansion, and the concentric circular structure is not obvious. Immunohistochemistry shows actin and desmin positive, while myopericytoma is desmin negative which can help the identification [11]. And in our report it showed immunoreactivity for SMA, EBER and caldesmon, and had a ki-67 index of about 10%. It revealed that the tumor is originated from smooth muscle, and the positive EBER further indicated that there may be some correlation with EBV. Negative desmin is an important marker for its differentiation from smooth muscle tumor. Reactivity of tumor cells for SMA, caldesmon, and the lack of CD34, CD117, DOG-1 reactivity can help to distinguish this tumor from solitary fibrous tumors and extra-gastrointestinal stromal tumor [12].



    Myopericytoma is a unique, though rare, type of tumor that can occur in AIDS patients. Its’ association with EBV may increase the disease spectrum of mesenchymal tumors associated with EBV. But more research is needed to reveal the mechanisms of how EBV causes the onset of the myopericytoma. Similar to smooth muscle tumors in immunodeficient hosts, myopericytomas in AIDS patients have many similarities in clinical features, and EBV positive myopericytomas may be found in future patients with congenital immune deficiency or iatrogenic immunosuppression [13]. Given its mimicry and the potential for malignancy, myopericytoma presents a unique challenge to surgeons and may be overlooked in differential diagnosis [2]. No standard medical treatment has been proven to be effective, and complete resection of the lesion may be the only effective treatment. Resection of the tumor is considered curative, but radiation is used in some cases to reduce recurrence. Variants of rarer myopericytomas with malignant progression have been reported, and ongoing molecular studies may confirm mutations or activated signaling pathways that may provide chemotherapy options in the future. Because the case is rare, there is no evidence for the effectiveness of drugs or radiotherapy. More case reports are needed to improve diagnosis and broaden treatment strategies [14].


    Declaration of Interest

    All authors have none to declare.



    The authors acknowledge the contribution of Mr. Su Junwei & Mr. Zhou Hengjun in this study. All authors have read and approved the manuscript and each author believes it represents honest work.



    1. Park HJ, Lee DR, Park MY, Choi YS, et al. (2010). A case of intravascular myopericytoma. J Clin Pathol. 63(9): 847-848.
    2. Morzycki A, Joukhadar N, Murphy A and Williams J. (2017). Digital Myopericytoma: A Case Report and Systematic Literature Review. J Hand Microsurg. 9(1): 32-36.
    3. Nagai T, Kamimura T, Itou K, Fuji M, et al. (2017). Myopericytoma in urinary bladder: a case report. J Med Case Rep. 11(1): 46.
    4. Mentzel T, Dei Tos AP, Sapi Z and Kutzner H. (2006). Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 30(1): 104-113.
    5. James AW, Chang L, Shrestha S, Tirado CA, et al. (2015). An unusual complex karyotype in myopericytoma. J Orthop. 12(1): 58-62.
    6. Oliveira RC, Velasco R, Santos GR and Rebelo O. (2018). Intracranial myopericytoma: a tumour in a rare location. BMJ Case Rep. 2018: bcr-2017-223111.
    7. Calderaro J, Polivka M, Gallien S, Bertheau P, et al. (2008). Multifocal Epstein Barr virus (EBV)-associated myopericytoma in a patient with AIDS. Neuropathol Appl Neurobiol. 34(1): 115-117.
    8. Jairajpuri ZS, Hasan MJ, Madan GB and Jetley S. (2016). Myopericytoma - a unifying term or a unique entity? Malays J Pathol. 38(2): 159-163.
    9. Aliotta RE, Veerkamp P, Durand P, Piliang M, et al. (2017). Traumatic Facial Myopericytoma: A Differential to Consider. J Craniofac Surg. 28(4): e327-e329.
    10. Dhingra S, Ayala A, Chai H, Moreno V, et al. (2012). Renal myopericytoma: case report and review of literature. Arch Pathol Lab Med. 136(5): 563-566.
    11. Matsuyama A, Hisaoka M and Hashimoto H. (2007). Angioleiomyoma: a clinicopathologic and immunohistochemical reappraisal with special reference to the correlation with myopericytoma. Hum Pathol. 38(4): 645-651.
    12. Ramdial PK, Sing Y, Deonarain J, Singh B, et al. (2011). Periampullary Epstein-Barr virus-associated myopericytoma. Hum Pathol. 42(9): 1348-1354.
    13. Lau PP, Wong OK, Lui PC, Cheung OY, et al. (2009). Myopericytoma in patients with AIDS: a new class of Epstein-Barr virus-associated tumor. Am J Surg Pathol. 33(11): 1666-1672.
    14. Chen W, Han L, Pang H, Duan L, et al. (2017). Primary malignant myopericytoma with cancer cachexia: Report of the first case and review of literature. Medicine (Baltimore). 96(49): e9064.

    Copyright: Chai ZH, et al. © 2019. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    © 2015 Mathews Open Access Journals. All Rights Reserved.

    Creative Commons License
    Open Access by Mathews Open Access Journals is licensed under a
    Creative Commons Attribution 4.0 International License.
    Based On a Work at